Persistent URL of this record https://hdl.handle.net/1887/3196549
Documents
-
- Download
- 1-s2.0-S2468294220300824-main
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing
- All authors
- Engelberts, P.J.; Hiemstra, I.H.; Jong, B. de; Schuurhuis, D.H.; Meesters, J.; Hernandez, I.B.; Oostindie, S.C.; Neijssen, J.; Brink, E.N. van den; Horbach, G.J.; Verploegen, S.; Labrijn, A.F.; Salcedo, T.; Schuurman, J.; Parren, P.W.H.I.; Breij, E.C.W.
- Date
- 2020-02-01
- Journal
- EBioMedicine
- Volume
- 52